Literature DB >> 14566008

Sensitization of neuronal A2A adenosine receptors after persistent D2 dopamine receptor activation.

Timothy A Vortherms1, Val J Watts.   

Abstract

Acute activation of Galpha(i/o)-coupled D2 dopamine receptors inhibits A2A adenosine receptor stimulation of adenylate cyclase. This antagonistic interaction between D2 dopamine and A2A adenosine receptors has been well documented; however, the effects of persistent activation of D2 dopamine receptors on subsequent A2A adenosine receptor signaling have not been explored. The present study investigated the effects of short-term (3-h) and long-term (18-h) activation of D2L dopamine receptors on subsequent A2A adenosine receptor stimulation of adenylate cyclase in CAD-D2L and NS20Y-D2L neuroblastoma cells. Short- and long-term activation of D2L dopamine receptors markedly increased 5'-N-methylcarboxamidoadenosine (MECA)-stimulated cyclic AMP accumulation 1.4-fold and 1.7-fold, respectively. D2L receptor-induced sensitization of A2A-stimulated cyclic AMP accumulation was blocked by the D2 antagonist spiperone and pertussis toxin pretreatment. In addition, persistent activation of A2A adenosine receptors resulted in 50% desensitization of subsequent MECA-stimulated cyclic AMP accumulation; however, MECA-induced desensitization of A2A adenosine receptors did not prevent completely quinpirole-induced sensitization of adenylate cyclase. These studies revealed a novel mode of regulation between D2L dopamine and A2A adenosine receptors and suggest a cooperative interaction in the regulation of cyclic AMP signaling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14566008     DOI: 10.1124/jpet.103.057083

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

Review 1.  Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders.

Authors:  K Fuxe; D Marcellino; D O Borroto-Escuela; M Guescini; V Fernández-Dueñas; S Tanganelli; A Rivera; F Ciruela; L F Agnati
Journal:  CNS Neurosci Ther       Date:  2010-03-16       Impact factor: 5.243

Review 2.  Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function.

Authors:  Kjell Fuxe; Sergi Ferré; Meritxell Canals; Maria Torvinen; Anton Terasmaa; Daniel Marcellino; Steven R Goldberg; William Staines; Kirsten X Jacobsen; Carmen Lluis; Amina S Woods; Luigi F Agnati; Rafael Franco
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 3.  Moonlighting proteins and protein-protein interactions as neurotherapeutic targets in the G protein-coupled receptor field.

Authors:  Kjell Fuxe; Dasiel O Borroto-Escuela; Wilber Romero-Fernandez; Miklós Palkovits; Alexander O Tarakanov; Francisco Ciruela; Luigi F Agnati
Journal:  Neuropsychopharmacology       Date:  2013-09-06       Impact factor: 7.853

4.  Internalization and desensitization of adenosine receptors.

Authors:  Elisabeth C Klaasse; Adriaan P Ijzerman; Willem J de Grip; Margot W Beukers
Journal:  Purinergic Signal       Date:  2007-11-13       Impact factor: 3.765

5.  Computer-assisted image analysis of caveolin-1 involvement in the internalization process of adenosine A2A-dopamine D2 receptor heterodimers.

Authors:  Susanna Genedani; Diego Guidolin; Giuseppina Leo; Monica Filaferro; Maria Torvinen; Amina S Woods; Kjell Fuxe; Sergi Ferré; Luigi F Agnati
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 6.  Fluorescent protein complementation assays: new tools to study G protein-coupled receptor oligomerization and GPCR-mediated signaling.

Authors:  Pierre-Alexandre Vidi; Karin F K Ejendal; Julie A Przybyla; Val J Watts
Journal:  Mol Cell Endocrinol       Date:  2010-07-21       Impact factor: 4.102

7.  Striatal adenosine A(2A) receptor-mediated positron emission tomographic imaging in 6-hydroxydopamine-lesioned rats using [(18)F]-MRS5425.

Authors:  Abesh Kumar Bhattacharjee; Lixin Lang; Orit Jacobson; Bidhan Shinkre; Ying Ma; Gang Niu; William C Trenkle; Kenneth A Jacobson; Xiaoyuan Chen; Dale O Kiesewetter
Journal:  Nucl Med Biol       Date:  2011-03-30       Impact factor: 2.408

8.  Ligand-induced regulation and localization of cannabinoid CB1 and dopamine D2L receptor heterodimers.

Authors:  Julie A Przybyla; Val J Watts
Journal:  J Pharmacol Exp Ther       Date:  2009-12-16       Impact factor: 4.030

9.  Behavioural and biochemical responses to morphine associated with its motivational properties are altered in adenosine A(2A) receptor knockout mice.

Authors:  A Castañé; L Wells; G Soria; S Hourani; C Ledent; I Kitchen; J Opacka-Juffry; R Maldonado; O Valverde
Journal:  Br J Pharmacol       Date:  2008-07-28       Impact factor: 8.739

Review 10.  Targeting Adenosine Signaling in Parkinson's Disease: From Pharmacological to Non-pharmacological Approaches.

Authors:  Luiza R Nazario; Rosane S da Silva; Carla D Bonan
Journal:  Front Neurosci       Date:  2017-11-23       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.